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Abstract: Three nectar honeys (eucalyptus, thyme and forest) and two 
honeydew honeys (fir and Metcalfa) from Italy were tested for their 
antibacterial activity against pathogens commonly associated with wound 
and burn infections, including Methicillin-Resistant Staphylococcus Aureus 
(MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE) and 
Vancomycin-Resistant Enterococcus Faecalis (VREF). All honeys 
showed bactericidal activity against the microorganisms used, with 
honeydew honeys being the most effective. They also inhibited, in a dose-
dependent manner, violacein production in Chromobacterium violaceum, 
thus demonstrating their ability to affect quorum sensing-regulated biofilm 
formation. Overall, the results obtained suggest that the honeys examined 
may have potential for developing natural antimicrobial compositions or 
dressings for the treatment of infected wounds or burns.  
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Introduction  
Resistance to antibiotics continues to rise worldwide, 
but the rate of discovery of new antibiotics has steadily 
decreased over the last 20 years (Livermore, 2011). The 
reasons behind the lack of antibiotic discoveries are 
diverse and include, among others, the poor return on 
investment, compared to drugs for chronic diseases, and 
regulatory burdens for smaller pharmaceutical 
companies (Silver, 2011). 
Infections caused by resistant pathogens can often be 
treated using antibiotic cocktails, that is, a combination 
of existing antibiotics with different mode of actions. 
However, the emergence of multi-resistant bacterial 
strains (Rossolini et al., 2014) and the formation of 
bacterial biofilms that are difficult, if not impossible, to 
eradicate (Wu et al., 2015) have prompted efforts to find 
alternatives to current antibiotic therapy. 
Honey is an ancient natural remedy for the treatment 
of infected wounds. With the advent of antibiotics, 
therapeutic applications of honey were largely abandoned, 
but recent studies on its antibacterial and wound healing 
properties have stimulated a renewed interest in its use 
(Vandamme et al., 2013). The results of these studies 
indicate that some types of honey have high in vitro 
activity against both Gram-positive and Gram-negative 
bacteria and support their use in the treatment of infections 
not responding to antibiotics (Kwakman et al., 2011). 
Another point of interest is that resistance to honey has 
never been reported to date, or any toxicity or side effects 
associated with its use have been found (Mandal and 
Mandal, 2011). Furthermore, honey seems to have more 
than just bactericidal activity, as it can affect Quorum 
Sensing (QS), i.e., the mechanism by which bacteria 
control gene expression in response to cell density 
(Maddocks and Jenkins, 2013). QS is implicated in a 
number of pathologically relevant events such as biofilm 
formation, drug resistance and virulence factor production. 
A study conducted by Truchado et al. (2009a) on 29 
unifloral honeys showed that most of them were capable 
of interfering with QS. Chestnut and linden honeys had 
the highest anti-QS activity, whereas orange and rosemary 
honeys were less effective. Later studies conducted on 
New Zealand manuka (Leptospermum scoparium) honey 
revealed that this type of honey can inhibit biofilm 
formation of clinically important pathogenic bacteria such 
as Staphylococcus aureus (Lu et al., 2014), Proteus 
mirabilis (Majtan et al., 2014) and Clostridium difficile 
(Hammond et al., 2014). 
Although the aforementioned studies provide 
encouraging evidence for the efficacy of honey in 
treating wound infections, there is a need to further 
explore this issue, particularly in relation to the anti-QS 
and anti-biofilm properties of honey. 
In this study we investigated the antibacterial 
potential of some Italian honeys against bacteria 




commonly associated with infected wounds. The 
bacterial strains examined included Methicillin-Resistant 
Staphylococcus Aureus (MRSA), Methicillin-Resistant 
Staphylococcus Epidermidis (MRSE) and Vancomycin-
Resistant Enterococcus Faecalis (VREF), three 
pathogens that are currently of great concern because of 
their implication in life-threatening nosocomial and 
community-acquired infections. 
Materials and Methods 
Chemicals 
Chloramphenicol (CAS 56-75-7), methicillin sodium 
salt (CAS 132-92-3), vancomycin (CAS 1404-90-6), 
oxacillin (CAS 66-79-5), dimethyl sulfoxide (DMSO, 
CAS 67-68-5), Mueller-Hinton Agar 2 (MH2) and 
Mueller–Hinton (MH) broth were purchased from 
Sigma-Aldrich (Milano, Italy). Nutrient Broth 6067 
(NB) was obtained from KairoSafe (Duino Aurisina, 
Italy). All other chemicals were analytical grade and 
used without further purification. 
Bacterial Strains 
Staphylococcus aureus (ATCC 43300), 
Staphylococcus epidermidis (ATCC 29887), Enterococcus 
faecalis (ATCC 51299), Burkholderia cepacia (ATCC 
25416), Pseudomonas aeruginosa (ATCC 10145) and 
Chromobacterium violaceum (LMG 1267) were 
purchased from KairoSafe (Duino Aurisina, Italy).  
Methicillin-resistant Staphylococcus epidermidis 
(MRSE), isolated from an infected surgical wound, 
was obtained from Tor Vergata University Hospital 
(Rome, Italy).  
Honeys 
Honeys were obtained from Rigoni di Asiago 
(Asiago, VI, Italy) and consisted of three nectar 
(eucalyptus, thyme and forest) and two honeydew (fir 
HD and Metcalfa HD) honeys. They were collected from 
beehives in different locations in Italy and cold 
processed at temperatures below 30°C. 
Honey samples were placed in glass containers and 
stored in the dark at room temperature until use. 
Honey Sterilization 
The honey samples tested were sterilized, after 
dissolution in the appropriate growth medium, by 
filtration on a 0.22 µm Millipore
®
 filter.  
Agar-Well Diffusion Assay 
Agar-well diffusion tests were carried out according 
to NCCLS guidelines as described in a previous paper 
(Fidaleo et al., 2010). Bacterial cells from an 
exponential-phase culture grown in MH broth were 
spread on the surface of agar (MH2) plates using a sterile 
swab soaked in the bacterial suspension. 9 mm wells 
were then cut in the agar and filled with 150 µL of 
honey. After 18 h incubation at 37°C, the plates were 
examined and the diameters of the inhibition zones 
measured. Chloramphenicol (30 µg), methicillin (5 µg) 
vancomycin (10 µg) and oxacillin (10 µg) were used as 
positive controls. 
Determination of MIC 
Minimum Inhibitory Concentration (MIC) was 
determined by the two-fold serial dilution technique. The 
starting honey solution (33% w/v) was prepared by 
dissolving each honey in MH broth. Bacteria from an 
exponential culture were inoculated at about 1.5×10
6
 
CFU/mL in tubes containing the appropriate honey 
concentration. Test tubes were incubated at 37 °C for 16-
18 h. Subcultures were then streaked on MH2 agar 
plates, which were incubated at 37°C for 18 h. Finally, 
the number of colonies formed on each plate was 
counted. The MIC value was determined as the lowest 
honey concentration giving complete inhibition of 
bacterial growth. 
Determination of MBC 
Minimum Bactericidal Concentration (MBC) was 
determined by the two-fold serial dilution technique. The 
starting honey solution (33% w/v) was prepared by 
dissolving each honey in MH broth. Bacteria from an 
exponential culture were inoculated at about 1.5×10
6
 
CFU/mL in tubes containing the appropriate honey 
concentration. Tubes were incubated at 37°C for 16-18 
h. Subcultures were then streaked on MH2 agar plates, 
which were incubated at 37°C for 18 h. Finally, the 
number of colonies formed on each plate was counted. 
The MBC value was determined as the lowest honey 
concentration killing 99.9% of the original inoculum. 
Anti-Quorum Sensing Activity Assay 
Anti-quorum sensing activity was determined by 
evaluating the ability of honey to inhibit the production 
of violacein in the C. violaceum model system as 
reported by Fidaleo et al. (2013). 
C. violaceum was cultured aerobically in NB at 28 °C 
for 16-18 h. Forty µL of the culture were inoculated in 
tubes containing the appropriate concentration of honey 
in MH to achieve a suspension equivalent to 0.5 
McFarland standard. Test tubes were incubated at 37°C 
for 18 h, after which time an aliquot of 1 mL was taken 
and centrifuged at 16,000×g for 10 min to precipitate the 
insoluble violacein. The culture supernatant was 
discarded and 1 mL of DMSO was added to the pellet. 
Then, the solution was centrifuged at 16,000×g for 10 
min and the amount of violacein in the supernatant was 
determined spectrophotometrically at 585 nm.  





Preliminary tests on the bacterial strains used showed 
that S. aureus ATCC 43300, S. epidermidis ATCC 
29887 (MRSE A) and S. epidermidis isolated from the 
infected wound (MRSE B) were methicillin resistant. S. 
aureus ATCC 43300 was also oxacillin resistant, while 
E. faecalis ATCC 51299 was vancomycin resistant. 
The results obtained by the agar-well diffusion method 
are presented in Fig. 1. The five honeys were all active, 
but to varying degrees, against the six pathogens tested. 
Metcalfa HD honey was the most effective, followed by 
fir HD, thyme, eucalyptus and forest honeys.  
In general, Gram-positive bacteria were more 
susceptible to honeys than Gram-negatives, with the 
exception of E. faecalis, whose sensitivity was 
comparable to that of B. cepacia and P. aeruginosa. 
To investigate the intrinsic antibacterial activity of 
honeys, i.e., to assess whether the observed inhibitory 
effects were bactericidal or bacteriostatic, the MIC 
and MBC for each bacterial strain were determined. 
The observed MICs and MBCs ranged from 8.33 to 
33.3% (w/v). Some representative results, referring to 
MRSA (Gram-positive) and B. cepacia (Gram-negative) 






Fig. 1. Antibacterial activity of honeys against the six pathogens tested. D is the diameter of inhibition zone 











Fig. 3. Average antibacterial and anti-QS activities of the five honeys 




Table 1. Minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) of honeys 
against MRSA and B. cepacia 
 MRSA  B. cepacia 
 ------------------------------------------------- 
 MIC MBC MIC MBC 
Honey type (% w/v) (% w/v) (% w/v) (% w/v) 
Forest 33.3 33.3 33.3 33.3 
Eucalyptus 8.33 16.7 16.7 16.7 
Thyme 8.33 8.33 16.7 16.7 
Fir HD 8.33 16.7 16.7 33.3 
Metcalfa HD 8.33 8.33 16.7 33.3 
 
Table 2. Minimum inhibitory concentration (MIC) of honeys 
against C. violaceum and percentage change in 
absorbance at 585 nm (∆A/A0) for honey 
concentrations ranging from 0.25 to 1% (w/v) 
  ∆A/A0 (%) 
 MIC ------------------------------------ 
Honey type (% w/v) 0.25% 0.5% 1% 
Forest 8.33 30.2 40.6 53.7 
Eucalyptus 2.08 27.9 55.8 90.7 
Thyme 2.08 35.9 62.0 87.9 
Fir HD 4.17 23.0 43.4 69.8 
Metcalfa HD 4.17 31.0 57.9 77.3 
 
Figure 2 shows the effect of honeys on violacein 
production in the C. violaceum model system. All 
honeys significantly reduced the production of violacein 
in a dose-dependent fashion. Furthermore, the inhibitory 
activity occurred at sub-MIC levels (Table 2), which 
demonstrates that the honeys were capable of interfering 
with the QS signaling system.  
From the observed percentage decrease in 
violacein production at low honey concentrations 
(0.25-1% w/v) (Table 2), the following order of 
effectiveness can be established: 
 
Thyme > eucalyptus > metcalfa HD > fir HD > forest  
 
Interestingly, the QS inhibitory activity order did 
not parallel the antibacterial activity order. This can be 
easily seen in Fig. 3, where the anti-QS activity of the 
honeys (calculated from the data in Table 2) is 
compared with their average anti-bacterial activity 
against the six pathogens tested. These results clearly 
suggest that different mechanisms are involved in the 
two phenomena. 
Discussion 
This study was focused on six pathogens (P. 
aeruginosa, B. cepacia, E. faecalis, MRSA and two 
strains of MRSE) that are frequently implicated in 
wound and burn infections. Management of these 
infections is complicated by the emergence of multiple 
drug resistance strains and by the fact that bacteria at 
the wound site are often organized in biofilm 
structures. Biofilms act as a barrier to the penetration of 
both immune system components and antimicrobials, 
making antibiotic treatment difficult and potentially 
unsuccessful (Hall et al., 2014). 
In a previous study on the effect of Italian honeys of 
different floral origin and geographical location on 
model bacteria, we found that they exhibited a wide 
range of antibacterial activity (Fidaleo et al., 2011). 
Some of them showed no activity at all, while others, 
like eucalyptus and fir HD honeys, were particularly 
effective. These two honeys were therefore included, 
together with thyme, forest and Metcalfa HD honeys, in 
the present study to assess their antibacterial and anti-QS 
activities against the selected pathogens. 
The first point that emerges from our data is that the 
honeys tested not only inhibited bacterial growth but also 
killed the bacteria. Methicillin-resistant Staphylococcus 
species (MRSA, MRSE A and MRSE B) were the most 
sensitive to honey. In recent years, MRSA and MRSE 
have become the most important cause of nosocomial 
and device-related infections. Their presence in infected 
wounds can cause delayed wound healing and other 
complications (Otto, 2009; Purrello et al., 2014). 
Furthermore, their ability to form biofilms on living or 
inert surfaces makes infections poorly responsive to 
antibiotic treatment (O’Gara and Humphreys, 2001). 
A second point to note is the higher sensitivity of 
Gram-positive bacteria to the honeys tested. This is in 
agreement with previously reported results for Maleysian 
(Zainol et al., 2013) and other (Cooper et al., 2002; 
Basualdo et al., 2007) honeys. Moreover, similar 
results were obtained in studies using essential oils 
(Andrade et al., 2014) and plant extracts (Klancnik et al., 
2010) as antimicrobial agents. The lower susceptibility 
of Gram-negative bacteria could be due to the presence, 
in these organisms, of an outer lipopolysaccharide 
membrane in addition to the inner peptidoglycan layer, 
hindering the penetration of bioactive components into 
the cell (Pagès et al., 2008). 
The precise mechanisms of action of honey are not 
fully understood. Evidence so far seems to indicate 
that different factors may contribute to the 
antibacterial properties of honey, including high 
osmolarity, low pH, hydrogen peroxide and the 
presence of non-peroxide components of flower or bee 
origin (Kwakman and Zaat, 2012).  
The high osmolarity of honey is due to the high 
content of sugars (∼80% wt/vol), which lowers water 
activity and inhibit bacterial growth. Although this factor 
may have some influence on bacterial growth in 
undiluted or low-diluted honeys, it is unlikely that it 
would be significant in our case, given the observed 
MICs and MBCs. Regarding hydrogen peroxide, we 
found that catalase treatment of the honeys did not cause 




appreciable changes in antibacterial activity (data not 
shown here). Thus, we can hypothesize that the 
antibacterial properties of the honeys tested are mainly 
due to the presence of active compounds whose identity 
remains to be established. 
To date, only a few substances, such as 
methylglyoxal in Manuka honey (Mavric et al., 2008) 
and the antimicrobial peptide bee defensin-1 in Revamil
®
 
honey (Kwakman et al., 2011), have been definitely 
identified as responsible for the antibacterial activity of 
those honeys. Other honey components, such as phenolic 
compounds originating from plant nectar or, in HD 
honeys, from excretions of plant-sucking insects, have 
been proposed as possible antibacterial agents. Several 
phenolics have so far been identified in honeys, 
including caffeic, p-coumaric and ellagic acids 
(Escuredo et al., 2012), diglycosyl flavonoids and 
terpenes (Massaro et al., 2014). While most of them 
have antibacterial activity, their contribution to the 
antibacterial properties of honey is still unclear. Because 
of the low concentrations at which these substances are 
present in honey, it is believed that their combination, 
rather than their individual occurrence, is responsible for 
the observed activity (Kwakman et al., 2011). Consistent 
with this hypothesis, some types of honey were found to 
synergistically enhance the activity of antibiotics having 
different mechanisms of action, suggesting that honey 
may contain multiple active components affecting more 
bacterial target sites (Jenkins and Cooper, 2012). 
The third and perhaps most important point emerging 
from the present study is the ability of the five honeys 
tested to inhibit QS. The possibility of controlling this 
cell-to-cell communication mechanism is considered 
crucial for the development of next-generation 
antimicrobials. This is because QS regulates the 
production of many virulence factors, including biofilm 
formation, which plays a key role in antibiotic resistance 
as well as the pathogenesis of many clinically relevant 
infections (Hall et al., 2014). 
QS involves the synthesis, excretion and detection 
of small signal molecules known as autoinducers. They 
consist of oligopeptides in Gram-positive bacteria and 
Acylated Homoserine Lactones (AHLs) in Gram-
negative bacteria. Except for the halogenated furanones 
from the red alga Delisea pulchra, most of the 
identified anti-QS compounds are of plant origin 
(Nazzaro et al., 2013).  
Very few studies have been conducted on QS 
inhibition by honey and no conclusive evidence has yet 
been obtained on the compounds responsible for it. In a 
study on acacia and multifloral Korean honeys, Lee et al. 
(2011) found that low concentrations of these honeys 
(0.5% v/v) were capable of reducing biofilm formation in 
an enterohemorrhagic E. coli strain. Glucose and fructose 
appeared to be the main contributors to biofilm inhibition, 
although this is not consistent with the fact that honeys 
having similar glucose and fructose content may behave in 
a very different way. Truchado et al. (2009b) studied the 
effect of chestnut honey and its aqueous and methanolic 
extracts on biofilm formation by Erwinia carotovora, 
Yersinia enterocolitica and Aeromonas hydrophila. 
Chestnut honey and the aqueous extract showed a 
significant QS inhibitory activity, while the methanolic 
extract did not have any effect. Furthermore, QS inhibition 
resulted from both the degradation of AHLs and the 
inhibition of AHL production by the bacterial strains. In 
another study on the inhibitory properties of selected 
phenolic compounds on two of the above strains (E. 
carotovora and Y. enterocolitica), it was found that some 
of them, including rutin, ellagic and chlorogenic acids, 
were capable of reducing the concentration of ALHs 
(Truchado et al., 2012). Recently, Savka et al. (2015) 
showed that pinocembrin, a flavonoid that regulates 
immune genes in the western honey bee Apis mellifera, can 
disrupt AHL-dependent QS in bacteria. This suggests that 
phenolic honey constituents may play a role in QS inhibition, 
although current evidence does not allow definitive 
conclusion to be drawn on their contribution. 
Conclusion 
The worldwide increase in antibiotic resistance and 
the shortage of new antibiotics are driving interest in 
novel antimicrobial agents acting through alternative 
mechanisms, such as inhibition of QS, which is known 
to control bacterial adhesion to surfaces, biofilm 
formation and stimulation of virulence. 
The honeys investigated in this study were found to 
have both bactericidal and anti-QS activities against 
human pathogens commonly associated with wound and 
burn infections. In particular, they exhibited high 
antibacterial activity against MRSA and MRSE, whose 
prevalence in nosocomial and community-acquired 
infections is increasing dramatically. These properties 
support their use to treat infections not responding to 
antibiotic therapy or to prevent biofilm formation on 
medical devices. Because of the low cost of honey, 
compared to antibiotics, the development of honey-based 
antibacterial products could also have important 
economic implications for the health care system. 
Future studies should provide insight into the 
mechanisms by which the honeys tested exert their 
beneficial effects and explore the possibility of 
blending different types of honey to maximize 
antibacterial efficacy. 
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